Skip to content
Search

Latest Stories

Suppressing pharmacy funding crisis analysis would be ‘outrageous’, warns NPA

NPA urges immediate release of pharmacy funding crises review
Underfunding has forced record numbers of pharmacy closures (gettyimages)

The NPA fears the report won’t be published until pharmacy funding consultations conclude, while CPE states there is no set timeline for finalising negotiations.

The National Pharmacy Association (NPA) has called on the NHS and the Department of Health to immediately publish the government-commissioned analysis of pharmacy underfunding and reveal the true scale of the crisis.

Commissioned by NHS England, the long-awaited independent review is expected to “lay bare the perilous financial state” of community pharmacies, which is a vital part of the nation’s health infrastructure.


However, the NPA is concerned that the government may delay its release until after current funding consultations are concluded.

The NPA argued that the public needs to understand the fragile nature of the pharmacy network before any new deal can be agreed.

It has also warned health officials not to hide “the true scale of funding needed to reverse a decade of swingeing cuts”, which has forced record numbers of pharmacy closures.

NPA chair Nick Kaye said: “It would be a scandal to keep that evidence buried secret and leave MPs, pharmacies and the public in the dark.”

He acknowledged that the new government has inherited a crisis in pharmacy funding and emphasised that it will need to take “strong action” to maintain access to medicines.

Highlighting that pharmacies are closing at an alarming rate and those that remain are being forced to cut opening hours to stay open, he called for “full and immediate transparency about the funding required to protect the pharmacy network upon which millions rely.”

The association has demanded an urgent resolution to budget discussions to ensure that much-needed funds reach hard pressed pharmacies.

“Pharmacies need an urgent conclusion to consultations on pharmacy funding that protects the network that is so vital to millions of people. They cannot wait,” Kaye said.

Work to influence government spending ongoing, says CPE

Meanwhile, Community Pharmacy England (CPE) has confirmed to Pharmacy Business that negotiations on the 2024/25 and 2025/26 funding framework are ongoing, with no definitive timeline set for their conclusion.

“This item in the 2025/26 workplan (which commences in April 2025) relates to work which goes into negotiations, analysis, and any necessary implementation work. Implementation work can go on for many months, depending on what is agreed, and work to influence Government spending is ongoing,” CPE stated.

When launching the funding consultation in January, pharmacy minister Stephen Kinnock reaffirmed his commitment to working closely with CPE to agree “a package of funding that is reflective of the important support that they provide to patients up and down the country.”

CPE chief executive Janet Morrison had said the committee would very carefully consider whether “the proposals that the government is putting on the table address the severity of the funding crisis in community pharmacy.”

She noted that while community pharmacy sector can play a vital role in delivering government’s long term health plans, this will only be possible if “the sector is put on a sustainable financial footing.”

More For You

Sukhi Basra named NPA vice-chair in historic leadership update with Olivier Picard as new chair

Olivier Picard steps up as NPA chair, Basra as vice-chair

Olivier Picard named new NPA chair

The National Pharmacy Association (NPA) has announced Olivier Picard as the organisation’s new chair.

Picard replaces Nick Kaye whose term comes to an end this week.

Keep ReadingShow less
 RPS honours Professor Tony Avery OBE for excellence in prescribing safety and patient care

Professor Tony Avery OBE

Pic credit: RPS

Professor Tony Avery OBE awarded RPS Honorary Fellowship

The Royal Pharmaceutical Society (RPS) Assembly has awarded an Honorary Fellowship to Professor Tony Avery OBE in recognition of his outstanding contribution to prescribing safety and patient care.

The Honorary Fellowship is given to those who are not eligible for membership of the Society but have either attained a distinction in a particular aspect or aspects of pharmacy, made a distinctive contribution to pharmacy or the RPS, distinguished themselves in any branches of knowledge referred to in the objects of the Society or achieved eminence in public life.

Keep ReadingShow less
US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

Pharma sector needs protecting from Trump tariffs, warn MPs

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less